# Natera, Inc. (NTRA)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NTRA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 1.45B | $ -152.06M | $ 9.40M | $ 238.49M | $ 1.82B |
| 2025 | $ 2.36B | $ -213.14M | $ 98.92M | $ 214.38M | $ 1.71B |
| 2024 | $ 1.78B | $ -200.15M | $ 72.78M | $ 187.12M | $ 1.20B |
| 2023 | $ 1.17B | $ -470.13M | $ -309.40M | $ 441.99M | $ 765.33M |
| 2022 | $ 916.27M | $ -611.95M | $ -535.31M | $ 446.22M | $ 705.74M |
| 2021 | $ 743.49M | $ -560.71M | $ -447.25M | $ 397.23M | $ 653.30M |
| 2020 | $ 498.11M | $ -292.68M | $ -257.48M | $ 281.09M | $ 486.24M |
| 2019 | $ 390.23M | $ -161.12M | $ -88.30M | $ 155.82M | $ 278.71M |
| 2018 | $ 340.28M | $ -169.25M | $ -98.34M | $ 123.51M | $ 32.16M |
| 2017 | $ 284.16M | $ -183.63M | $ -143.68M | $ 123.18M | $ 25.42M |
| 2016 | $ 298.66M | $ -131.76M | $ -133.51M | $ 49.62M | $ 106.48M |
| 2015 | $ 267.27M | $ -98.67M | $ -64.14M | $ 42.09M | $ 184.77M |
| 2014 | $ 225.08M | $ -7.28M | $ 753.1K | $ 26.81M | $ -171.34M |
| 2013 | $ 62.73M | $ -39.99M | $ -25.98M | $ 24.31M | $ 13.69M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.13 |
| Liabilities / Eq | 0.46 |
| Current Ratio | 3.00 |

## Other views

- [Metrics](https://sponda.capital/en/NTRA.md)
- [Charts](https://sponda.capital/en/NTRA/charts.md)
- [Compare](https://sponda.capital/en/NTRA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.